DB07268, 99%, a potent and selective JNK1 inhibitor with an IC50 value of 9 nM

Name: DB07268, 99%, a potent and selective JNK1 inhibitor with an IC50 value of 9 nM | 929007-72-7
Brand: J&K Chemical
SKU: JK2286624_5_MG
Price: 311.9 USD
Availability: OutOfStock

Cat. No JK2286624_5_MG

Vendor: J&K Chemical

Product Information

Product Name

DB07268, 99%, a potent and selective JNK1 inhibitor with an IC50 value of 9 nM

Brand Name

J&K

Product Number

2286624

CAS

929007-72-7

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

16058637

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Publication Name: Nucleic Acids Research

Publication Date: 2024-11-22

DOI: 10.1093/nar/gkae1075

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872

Target Class Profiling of Small-Molecule Methyltransferases

Publication Name: ACS Chemical Biology

Publication Date: 2023-03-28

DOI: 10.1021/acschembio.3c00124

Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors

Publication Name: Proceedings of the National Academy of Sciences of the United States of America

Publication Date: 2020-11-23

DOI: 10.1073/pnas.2005463117

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle

Publication Name: ACS Chemical Biology

Publication Date: 2020-05-27

DOI: 10.1021/acschembio.0c00343

DB07268, 99%, a potent and selective JNK1 inhibitor with an IC50 value of 9 nM

Product Information

General Information

Safety Information

References Data Source From Pubchem

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Target Class Profiling of Small-Molecule Methyltransferases

Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle